Home
welcome important dates general information program register submit abstract scientific committee corporate support secretariat
  Welcome December 13-18, 2002, The Ritz-Carlton, Naples, Florida  


The deadline for abstract submission is Friday, November 1, 2002. All submissions should not exceed 450 words.

The Scientific Committee requests that authors submit their abstracts electronically via the Conference website. To submit electronically please click on the button at the bottom of the page (Deadline has passed) and follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word or RTF format.

Abstract Content
  1. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow a structured format, indicating in bold the four parts of the abstract:

    Background: the problem under investigation or a hypothesis;
    Methods: the experimental methods used;
    Results: the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers;
    Conclusion: a summary of the findings. It is unacceptable to use statements such as "the results will be discussed".

  2. Clearly define all concepts and abbreviations at first use.
  3. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker.
Abstract Format
Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
  • Drug Design and Discovery: Viral Targets
  • Chemistry and Pre-Clinical Development
  • Viral Resistance
  • Phenotypic and Genotypic Assays
  • Pharmacology
  • Immunotherapy in HIV Infection
  • First-line and Salvage Therapy
  • Treatment Failure and Drug Interactions
  • Pediatrics
  • HIV/Hepatitis and Other Co-infections
  • Vaccines/Therapeutic Vaccines

Title
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Authors
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. PM Coker, J Ballard, and
AP Deutsch).

Affiliations
All affiliations should follow the last author's name and be referenced with superscript numbers. Each author should be listed by institution, city, and state (2 letter postal abbreviation) or country.

Keywords
Provide up to three keywords. These keywords are completely independent of each other and should be able to stand alone in the index. Words should be lowercase, except for genus names and proper nouns.

Contact Information
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily.

Sample Abstract
To view a sample abstract, click here.

The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.

Abstract Notifications
Notifications of acceptance and format of presentation (oral or poster presentation) will be Friday, November 15, 2002. It is the responsibility of the corresponding/presenting author to inform all co-authors of the disposition status. If you have not received notification by November 20, 2002, please call +1 770 946 3480.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your poster presentations will be sent if your abstract is accepted. It is suggested that all accepted posters be set up prior to Monday, December 16, 2002.

Published Abstract Book
Accepted abstracts will be standardized in font and presentation. Abstracts will NOT be edited in any way. Thus, any error that appears in the submitted abstract will appear in the printed abstract.

Subject to availability, copies of the Abstracts on CD and the Abstract Book will be available for sale after the Conference. Please contact the Conference Secretariat.

Copyright © 2002 Informed Horizons, LLC
Design: eclipse-design.com
All rights reserved, Additional copyright information also applies.